Literature DB >> 1387093

Lp(a) and the risk of coronary heart disease.

M Bihari-Varga1, G Kostner, A Czinner.   

Abstract

A screening study was performed on 106 children with familial risk for coronary heart disease (CHD) and on matched controls. The two groups differed in several parameters. Children of CHD patients exhibited significantly elevated levels of Lp(a) and total cholesterol, reduced HDL apo A1 and apo A2 and increased values of serum hexuronic acid. These results support the concept that genetic and familial factors contribute to the risk of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387093     DOI: 10.1007/bf00145347

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

Authors:  K BERG
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

3.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

Authors:  A Murai; T Miyahara; N Fujimoto; M Matsuda; M Kameyama
Journal:  Atherosclerosis       Date:  1986-02       Impact factor: 5.162

4.  Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease.

Authors:  K Berg; G Dahlén; M H Frick
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

5.  Lipoprotein Lp(a) and the risk for myocardial infarction.

Authors:  G M Kostner; P Avogaro; G Cazzolato; E Marth; G Bittolo-Bon; G B Qunici
Journal:  Atherosclerosis       Date:  1981 Jan-Feb       Impact factor: 5.162

6.  Turnover of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

7.  Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans?

Authors:  G M Kostner; M Bihari-Varga
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

8.  Black-white differences in serum Lp(a) lipoprotein levels.

Authors:  H J Parra; I Luyéyé; C Bouramoué; C Demarquilly; J C Fruchart
Journal:  Clin Chim Acta       Date:  1987-09-15       Impact factor: 3.786

9.  Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta.

Authors:  M Bihari-Varga; E Gruber; M Rotheneder; R Zechner; G M Kostner
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

10.  A semi-quantitative micromethod for the determination of free glycosaminoglycans in serum. Results from studies on serum of healthy children of various age and patients affected by mucopolysaccharidosis.

Authors:  J Melet; G J Hooghwinkel; M A Giesberts; H H van Gelderen
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

View more
  1 in total

1.  Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease.

Authors:  M De Simone; A Verrotti; M Cappa; L Iughetti; E Di Cesare; M Palumbo; R Bernabei; T Rosato
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.